Expression analysis of cytokine transcripts in inflammatory demyelinating polyradiculoneuropathy
Fwad Nicknafs1, Soudeh Ghafouri-Fard1, Mir Davood Omrani1
1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Metabolic Brain Disease
|June 25, 2021
Summary
This study found altered levels of cytokines like IL-17A, IL-6, TGF-B, and IL-1B in patients with inflammatory demyelinating polyradiculoneuropathies (IDPs). These cytokine changes suggest a role in the pathogenesis of acute (AIDP) and chronic (CIDP) forms of these conditions.
Area of Science:
- Immunology
- Neuroscience
- Genetics
Background:
- Inflammatory demyelinating polyradiculoneuropathies (IDPs) involve immune dysregulation affecting the peripheral nervous system.
- Cytokines play a crucial role in modulating immune responses within these neurological disorders.
Purpose of the Study:
- To compare the transcript levels of nine key cytokine-coding genes in patients with acute (AIDP) and chronic (CIDP) IDPs versus healthy controls.
- To investigate the potential role of specific cytokines in the pathogenesis of AIDP and CIDP.
Main Methods:
- Quantitative analysis of cytokine gene (IL-1B, IL-2, IL-4, IL-6, IL-8, IL-17A, IFN-G, TGF-B, TNF-A) transcript levels in peripheral blood.
- Comparison of gene expression patterns between female AIDP patients, female CIDP patients, and female healthy controls.
- Assessment of diagnostic power for specific cytokines in differentiating between patient groups and controls.
Main Results:
- Significantly lower IL-17A expression in female AIDP patients compared to controls.
- Elevated IL-17A in female CIDP patients versus female AIDP patients.
- Reduced IL-6 and TGF-B expression observed in female AIDP patients.
- Lower IL-1B transcript levels noted in overall CIDP cases and in female AIDP cases compared to controls, with a significant increase in female CIDP versus female AIDP.
- IL-4, IL-1B, and TNF-A demonstrated diagnostic potential in distinguishing between different IDP subtypes and controls.
Conclusions:
- The study highlights differential expression of IL-17A, IL-6, TGF-B, and IL-1B in AIDP and CIDP, suggesting their involvement in disease pathogenesis.
- Specific cytokine profiles may serve as biomarkers for differentiating between acute and chronic inflammatory demyelinating polyradiculoneuropathies.
